Cardiac microtissues from human pluripotent stem cells recapitulate the phenotype of long-QT syndrome

被引:9
|
作者
Giacomelli, Elisa [1 ,2 ]
Sala, Luca [1 ,3 ,4 ]
Ward-van Oostwaard, Dorien [1 ]
Bellin, Milena [1 ,5 ,6 ]
机构
[1] Leiden Univ Med Ctr LUMC, Dept Anat & Embryol, NL-2333 ZA Leiden, Netherlands
[2] Sloan Kettering Inst Canc Res, Dev Biol Program, Ctr Stem Cell Biol, New York, NY USA
[3] Ist Auxol Italiano IRCCS, Ctr Cardiac Arrhythmias Genet Origin, Milan, Italy
[4] Lab Cardiovasc Genet, Milan, Italy
[5] Univ Padua, Dept Biol, I-35121 Padua, Italy
[6] Veneto Inst Mol Med, I-35129 Padua, Italy
基金
欧洲研究理事会;
关键词
Cardiac microtissue; Human pluripotent stem cell cardiomyocyte; Long-QT syndrome; Multi-electrode array; Drug screening; CARDIOMYOCYTES; MODELS;
D O I
10.1016/j.bbrc.2021.07.068
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Human induced pluripotent stem cells (hiPSCs) and their derivative cardiomyocytes (hiPSCCMs) have been successfully used to study the electrical phenotype of cardiac ion channel diseases. However, strategies to mature CMs and more comprehensive systems recapitulating the heart complexity are required to advance our ability to capture adult phenotypes. Methods: We differentiated wild-type (WT) and long QT syndrome type 1 (LQT1) hiPSCs into CMs, endothelial cells and cardiac fibroblasts. The three cell types were combined to form three-dimensional (3D) spheroids, termed "cardiac microtissues" (cMTs) and the electrophysiological properties were measured using 96-well multi-electrode arrays. Results: LQT1 cMTs displayed prolonged field potential duration compared to WT controls, thus recapitulating the typical feature of LQTS. Isoprenaline caused a positive chronotropic effect on both LQT1 and WT cMTs. The 96-well multi-electrode array format proved suitable to detect electrical changes directly in the 3D tissues. Conclusions: 3D hiPSC cMTs are a scalable tool that can be used to identify LQT electrical hallmarks and drug responses. We anticipate this tool can be adopted by pharmaceutical companies to screen cardioactive compounds. (c) 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:118 / 124
页数:7
相关论文
共 50 条
  • [41] Genotype-phenotype aspects of type-2 Long-QT syndrome
    Shah, Samit
    Amin, Vinit
    Castle, John
    Goldenberg, Ilan
    Moss, Arthur J.
    McNitt, Scott
    Lopes, Coeli
    Zareba, Wojciech
    Robinson, Jennifer L.
    Polonsky, Slava
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 37A - 37A
  • [42] Percutaneous Left Cardiac Sympathetic Denervation in a Patient With Long-QT Syndrome
    Nagels, Werner
    Brabant, Steven
    Van Aelst, Lucas
    Pollet, Peter
    Anne, Wim
    Goethals, Marnix
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2014, 28 (06) : 1580 - 1582
  • [43] Functional arrays of human pluripotent stem cell-derived cardiac microtissues
    Thavandiran, Nimalan
    Hale, Christopher
    Blit, Patrick
    Sandberg, Mark L.
    McElvain, Michele E.
    Gagliardi, Mark
    Sun, Bo
    Witty, Alec
    Graham, George
    Do, Van T. H.
    Bakooshli, Mohsen Afshar
    Le, Hon
    Ostblom, Joel
    McEwen, Samuel
    Chau, Erik
    Prowse, Andrew
    Fernandes, Ian
    Norman, Andreea
    Gilbert, Penney M.
    Keller, Gordon
    Tagari, Philip
    Xu, Han
    Radisic, Milica
    Zandstra, Peter W.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [44] Functional arrays of human pluripotent stem cell-derived cardiac microtissues
    Nimalan Thavandiran
    Christopher Hale
    Patrick Blit
    Mark L. Sandberg
    Michele E. McElvain
    Mark Gagliardi
    Bo Sun
    Alec Witty
    George Graham
    Van T.H. Do
    Mohsen Afshar Bakooshli
    Hon Le
    Joel Ostblom
    Samuel McEwen
    Erik Chau
    Andrew Prowse
    Ian Fernandes
    Andreea Norman
    Penney M. Gilbert
    Gordon Keller
    Philip Tagari
    Han Xu
    Milica Radisic
    Peter W. Zandstra
    Scientific Reports, 10
  • [45] Re-trafficking of hERG reverses Long QT Syndrome 2 phenotype in human pluripotent stem cell derived cardiomyocytes
    Mehta, A.
    Sequiera, G. L.
    Ramachandra, C. J. A.
    Sudibyo, Y.
    Chung, Y. Y.
    Wong, Y. W.
    Tan, T. H.
    Liew, R.
    Wong, P.
    Shim, W.
    EUROPEAN HEART JOURNAL, 2013, 34 : 276 - 276
  • [46] Human Induced Pluripotent Stem Cells Validate a Novel Iks Activator as a Potential Therapeutic for Long QT Syndrome
    Acha, Moshe Rav
    Nakamura, Kenta
    Mills, Robert
    Lynch, Stacey
    Hinson, Travis
    Ellinor, Patrick
    Conklin, Bruce R.
    Wu, Sean
    Milan, David J.
    CIRCULATION, 2012, 126 (21)
  • [47] Three-dimensional cardiac microtissues composed of cardiomyocytes and endothelial cells co-differentiated from human pluripotent stem cells
    Giacomelli, Elisa
    Bellin, Milena
    Sala, Luca
    Van Meer, Berend J.
    Tertoolen, Leon G. J.
    Orlova, Valeria V.
    Mummery, Christine L.
    DEVELOPMENT, 2017, 144 (06): : 1008 - 1017
  • [48] Induced pluripotent stem cell models of long QT syndrome
    Li, Guoliang
    Pan, Junqiang
    Zhang, Aifeng
    Sun, Chaofeng
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (03) : 3127 - 3129
  • [49] MODELING BARTH SYNDROME CARDIAC PHENOTYPE WITH HUMAN PLURIPOTENT STEM CELLS DERIVED CARDIOMYOCYTES (IPS-CM)
    Fatica, Erica
    Sandlers, Yana
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (03) : 229 - 229
  • [50] Propranolol Inhibits Late Sodium Current in Long-QT Syndrome Type 3 Human Induced Pluripotent Stem Cell-drived Myocyte Model
    Hirose, Sayako
    Makiyama, Takeru
    Melgari, Dario
    Wu, Jie
    Yokoi, Fumika
    Wuriyanghai, Yimin
    Yamamoto, Yuta
    Kohjitani, Hirohiko
    Nishiuchi, Suguru
    Harita, Takeshi
    Hayano, Mamoru
    Yoshimoto, Jun
    Ohno, Seiko
    Yoshida, Yoshinori
    Horie, Minoru
    Kimura, Takeshi
    CIRCULATION, 2017, 136